Items where authors include "Ridd, M.J."

Article

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ow, P.-L., Alderson, S.L. et al. (11 more authors) (2025) Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial. Gut. ISSN 0017-5749

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ford, A.C. orcid.org/0000-0001-6371-4359, Alderson, S.L. orcid.org/0000-0002-5418-0495 et al. (19 more authors) (2024) Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT. Health Technology Assessment, 28 (66). ISSN 1366-5278

Teasdale, E., Everitt, H., Alderson, S. et al. (19 more authors) (2024) Low-dose amitriptyline for irritable bowel syndrome (IBS): a qualitative study of patients' and GPs' views and experiences. British Journal of General Practice. BJGP.2024.0303. ISSN 0960-1643

Bradshaw, L.E. orcid.org/0000-0001-8382-6040, Wyatt, L.A. orcid.org/0000-0002-9817-5356, Brown, S.J. orcid.org/0000-0002-3232-5251 et al. (22 more authors) (2024) Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT. Health Technology Assessment, 28 (29). ISSN 1366-5278

Ford, A.C., Wright-Hughes, A., Alderson, S.L. et al. (65 more authors) (2023) Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. ISSN 0140-6736

Sach, T.H. orcid.org/0000-0002-8098-9220, Lartey, S.T., Davies, C. et al. (20 more authors) (2023) Emollients for preventing atopic eczema: cost‐effectiveness analysis of the BEEP trial. Clinical & Experimental Allergy, 53 (10). pp. 1011-1019. ISSN 0954-7894

Bradshaw, L.E., Wyatt, L.A., Brown, S.J. et al. (22 more authors) (2023) Emollients for prevention of atopic dermatitis; 5‐year findings from the BEEP randomised trial. Allergy, 78 (4). pp. 995-1006. ISSN 1398-9995